1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Epkin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors OKN4395, Pembrolizumab, Fasting - Solid Tumours, Sarcoma | Phase 1 | Recruiting | Epkin | 146 | 2025-01-23 | 2026-06-11 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Dermatofibrosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Sarcoma (1) · Solitary Fibrous Tumors (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Angptl4 protein, mouse (1) · Famotidine (1) · Histamine H2 Antagonists (1) · pembrolizumab (1)
Australia (1) · United Kingdom (1) · United States (1)